Clinical Trial Update: Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 study update for ProstAtak immunotherapy with standard radiation therapy in localized prostate cancer; trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ProstAtak

Snippet

Sponsor: Candel Therapeutics, Inc. | Conditions: Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING